News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
April 1st 2004

Trending on AJMC

Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble

5 Things to Know if Retatrutide Is Classified as a Biologic

Sacral Neuromodulation Still Seen as OAB Gold Standard in Review

FDA Approves Tucatinib Maintenance for HER2+ Metastatic Breast Cancer

CMS Moves TIC Reporting to Quarterly, Sets Drug File Timeline